General Commentary

Published on 26 Jan 2021

Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

in Respiratory Pharmacology

Sergio Verd
Mateo Verd

Frontiers in Pharmacology

doi 10.3389/fphar.2020.625295

5,935 views
3 citations

Original Research

Published on 20 Jan 2021

Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair

in Respiratory Pharmacology

Xinhui Wu
Vicky Verschut
Manon E. Woest
John-Poul Ng-Blichfeldt
Ana Matias
Gino Villetti
Alessandro Accetta
Fabrizio Facchinetti
Reinoud Gosens
Loes E. M. Kistemaker

Frontiers in Pharmacology

doi 10.3389/fphar.2020.609509

6,572 views
19 citations

Original Research

Published on 13 Jan 2021

MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation

in Respiratory Pharmacology

Xionghua Sun
Mei Zhu
Xihua Chen
Xiaogang Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.573524

4,479 views
15 citations

Original Research

Published on 08 Jan 2021

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

in Respiratory Pharmacology

Chung-Yu Chen
Wen-Ting Wu
Ya-Ling Wang
Kuang-Ming Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2020.613761

3,093 views
4 citations

Original Research

Published on 08 Jan 2021

Alda-1 Attenuates Hyperoxia-Induced Acute Lung Injury in Mice

in Respiratory Pharmacology

Sahebgowda Sidramagowda Patil
Helena Hernández-Cuervo
Jutaro Fukumoto
Sudarshan Krishnamurthy
Muling Lin
Matthew Alleyn
Mason Breitzig
Venkata Ramireddy Narala
Ramani Soundararajan
Richard F. Lockey

Frontiers in Pharmacology

doi 10.3389/fphar.2020.597942

5,219 views
20 citations

Original Research

Published on 16 Dec 2020

Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis

in Respiratory Pharmacology

Fei Gao
Yun Zhang
Zhizhou Yang
Mengmeng Wang
Zhiyi Zhou
Wei Zhang
Yi Ren
Xiaoqin Han
Mei Wei
Zhaorui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2020.584098

4,372 views
22 citations

Case Report

Published on 15 Dec 2020

Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

in Respiratory Pharmacology

Walter Conca
Ihab Weheba
Mohei-Eldin Abouzied
Abeer Abdelsayed
Yousif Aleyouni
Eid Al‐Mutairy
Nasir Bakshi
Mohammad Khalid

Frontiers in Pharmacology

doi 10.3389/fphar.2020.585761

7,204 views
8 citations

Original Research

Published on 11 Dec 2020

Melatonin Attenuates Sepsis-Induced Acute Lung Injury Through Improvement of Epithelial Sodium Channel-Mediated Alveolar Fluid Clearance Via Activation of SIRT1/SGK1/Nedd4-2 Signaling Pathway

in Respiratory Pharmacology

Jing Li
Longfei Liu
Xiaojun Zhou
Xianzhou Lu
Xianrong Liu
Guojuan Li
Jianwu Long

Frontiers in Pharmacology

doi 10.3389/fphar.2020.590652

3,925 views
20 citations

Perspective

Published on 11 Dec 2020

Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation

in Respiratory Pharmacology

Chengliang Yang
Shaf Keshavjee
Mingyao Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2020.615398

11,347 views
39 citations

Original Research

Published on 09 Dec 2020

Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease

in Respiratory Pharmacology

Yi-Hsiang Liao
Liang-Yu Chen
Kuang-Ming Liao
Chung-Yu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.592910

2,689 views
8 citations

Original Research

Published on 08 Dec 2020

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist

in Respiratory Pharmacology

Hélène Salvator
Amparo Buenestado
Marion Brollo
Emmanuel Naline
Tatiana Victoni
Elisabeth Longchamp
Hermann Tenor
Stanislas Grassin-Delyle
Philippe Devillier

Frontiers in Pharmacology

doi 10.3389/fphar.2020.598702

3,213 views
5 citations

Hypothesis and Theory

Published on 26 Nov 2020

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities

in Respiratory Pharmacology

Jonathan D. Geiger
Nabab Khan
Madhuvika Murugan
Detlev Boison

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594487

8,119 views
28 citations

Original Research

Published on 26 Nov 2020

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

in Respiratory Pharmacology

Yukari Satsuma
Hiroaki Ikesue
Kaori Kusuda
Mami Maeda
Nobuyuki Muroi
Ryobu Mori
Mariko Kogo
Ryosuke Hirabayashi
Kazuma Nagata
Atsushi Nakagawa

Frontiers in Pharmacology

doi 10.3389/fphar.2020.529654

3,057 views
8 citations

Original Research

Published on 10 Nov 2020

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

in Respiratory Pharmacology

Fatih M. Uckun
James Carlson
Cemal Orhan
Joy Powell
Natalie M. Pizzimenti
Hendrik van Wyk
Ibrahim H. Ozercan
Michael Volk
Kazim Sahin

Frontiers in Pharmacology

doi 10.3389/fphar.2020.594321

10,238 views
20 citations

Review

Published on 28 Oct 2020

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

in Respiratory Pharmacology

Hongwei Peng
Zhangren Chen
Yunyun Wang
Simei Ren
Tiantian Xu
Xin Lai
Jinhua Wen
Mengjun Zhao
Chuanfei Zeng
Lijuan Du

Frontiers in Pharmacology

doi 10.3389/fphar.2020.554172

5,817 views
8 citations

Original Research

Published on 22 Oct 2020

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

in Respiratory Pharmacology

Jizhen Huang
Xiang Tong
Li Zhang
Yuan Zhang
Lei Wang
Dongguang Wang
Shijie Zhang
Hong Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.550955

6,637 views
42 citations

Navigation group

Articles

Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair

MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

Alda-1 Attenuates Hyperoxia-Induced Acute Lung Injury in Mice

Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis

Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

Melatonin Attenuates Sepsis-Induced Acute Lung Injury Through Improvement of Epithelial Sodium Channel-Mediated Alveolar Fluid Clearance Via Activation of SIRT1/SGK1/Nedd4-2 Signaling Pathway

Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation

Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease

Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice